Loading clinical trials...
Loading clinical trials...
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead: The Dx-AF Study
Conditions
Interventions
VDD ICD (experimental group)
Single chamber VVI ICD (control group)
Locations
9
Canada
Royal Alexandra Hospital
Edmonton, Alberta, Canada
Vancouver Island Health Authority
Vancouver, British Columbia, Canada
Saint John Regional Hospital
Saint John, New Brunswick, Canada
Health Sciences North
Greater Sudbury, Ontario, Canada
Scarborough and Rouge Hospital - Centenary Site
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Start Date
March 31, 2017
Primary Completion Date
March 31, 2022
Completion Date
March 31, 2022
Last Updated
April 30, 2021
NCT07547098
NCT07491315
NCT07487363
NCT06909773
NCT06505109
NCT06189313
Lead Sponsor
Unity Health Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions